These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34487174)

  • 1. B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis.
    McMillan M; Koehler AP; Lawrence A; Sullivan TR; Bednarz J; MacLennan JM; Maiden MCJ; Ladhani SN; Ramsay ME; Trotter C; Borrow R; Finn A; Kahler CM; Whelan J; Vadivelu K; Richmond PC; Marshall HS
    J Infect Dis; 2022 Feb; 225(4):637-649. PubMed ID: 34487174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of
    Marshall HS; McMillan M; Koehler A; Lawrence A; MacLennan J; Maiden M; Ramsay M; Ladhani SN; Trotter C; Borrow R; Finn A; Sullivan T; Richmond P; Kahler C; Whelan J; Vadivelu K
    BMJ Open; 2019 May; 9(5):e027233. PubMed ID: 31064808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
    Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
    BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.
    Marshall HS; McMillan M; Koehler AP; Lawrence A; Sullivan TR; MacLennan JM; Maiden MCJ; Ladhani SN; Ramsay ME; Trotter C; Borrow R; Finn A; Kahler CM; Whelan J; Vadivelu K; Richmond P
    N Engl J Med; 2020 Jan; 382(4):318-327. PubMed ID: 31971677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
    Read RC; Baxter D; Chadwick DR; Faust SN; Finn A; Gordon SB; Heath PT; Lewis DJ; Pollard AJ; Turner DP; Bazaz R; Ganguli A; Havelock T; Neal KR; Okike IO; Morales-Aza B; Patel K; Snape MD; Williams J; Gilchrist S; Gray SJ; Maiden MC; Toneatto D; Wang H; McCarthy M; Dull PM; Borrow R
    Lancet; 2014 Dec; 384(9960):2123-31. PubMed ID: 25145775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4CMenB vaccine and its role in preventing transmission and inducing herd immunity.
    McMillan M; Marshall HS; Richmond P
    Expert Rev Vaccines; 2022 Jan; 21(1):103-114. PubMed ID: 34747302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
    Carr JP; MacLennan JM; Plested E; Bratcher HB; Harrison OB; Aley PK; Bray JE; Camara S; Rodrigues CMC; Davis K; Bartolf A; Baxter D; Cameron JC; Cunningham R; Faust SN; Fidler K; Gowda R; Heath PT; Hughes S; Khajuria S; Orr D; Raman M; Smith A; Turner DPJ; Whittaker E; Williams CJ; Zipitis CS; Pollard AJ; Oliver J; Morales-Aza B; Lekshmi A; Clark SA; Borrow R; Christensen H; Trotter C; Finn A; Maiden MC; Snape MD;
    Clin Microbiol Infect; 2022 Dec; 28(12):1649.e1-1649.e8. PubMed ID: 35840033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
    McMillan M; Chandrakumar A; Wang HLR; Clarke M; Sullivan TR; Andrews RM; Ramsay M; Marshall HS
    Clin Infect Dis; 2021 Aug; 73(3):e609-e619. PubMed ID: 33212510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents.
    McMillan M; Wang B; Koehler AP; Sullivan TR; Marshall HS
    Clin Infect Dis; 2021 Jul; 73(1):e233-e237. PubMed ID: 33587122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of
    Marshall HS; McMillan M; Koehler A; Lawrence A; MacLennan JM; Maiden MCJ; Ramsay M; Ladhani SN; Trotter C; Borrow R; Finn A; Sullivan T; Richmond P; Kahler CM; Whelan J; Vadivelu K
    BMJ Open; 2018 Jul; 8(7):e020988. PubMed ID: 29991629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Meningococcal B (4CMenB) Vaccine on Pharyngeal Neisseria meningitidis Carriage Density and Persistence in Adolescents.
    McMillan M; Walters L; Sullivan T; Leong LEX; Turra M; Lawrence A; Koehler AP; Finn A; Andrews RM; Marshall HS
    Clin Infect Dis; 2021 Jul; 73(1):e99-e106. PubMed ID: 32447370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results.
    MacLennan JM; Rodrigues CMC; Bratcher HB; Lekshmi A; Finn A; Oliver J; Wootton M; Ray S; Cameron C; Smith A; Heath PT; Bartolf A; Nolan T; Hughes S; Varghese A; Snape MD; Sewell R; Cunningham R; Stolton A; Kay C; Palmer K; Baxter D; Suggitt D; Zipitis CS; Pemberton N; Jolley KA; Bray JE; Harrison OB; Ladhani SN; Pollard AJ; Borrow R; Gray SJ; Trotter C; Maiden MCJ
    Lancet Infect Dis; 2021 May; 21(5):677-687. PubMed ID: 33482143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study.
    Wang B; Giles L; Andraweera P; McMillan M; Almond S; Beazley R; Mitchell J; Lally N; Ahoure M; Denehy E; Koehler A; Flood L; Marshall H
    Lancet Infect Dis; 2022 Jul; 22(7):1011-1020. PubMed ID: 35427492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.
    Fazio C; Biolchi A; Neri A; Tomei S; Vacca P; Ambrosio L; Palmieri A; Mori E; La Gaetana R; Pizza M; Giuliani MM; Serino L; Stefanelli P
    Hum Vaccin Immunother; 2021 Jul; 17(7):2225-2231. PubMed ID: 33522380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular characteristics of Neisseria meningitidis carriage strains in university students in Lithuania.
    Ivaškevičienė I; Silickaitė J; Mačionienė A; Ivaškevičius R; Bulavaitė A; Gėgžna V; Kiverytė S; Paškevič B; Žvirblienė A; Plečkaitytė M
    BMC Microbiol; 2023 Nov; 23(1):352. PubMed ID: 37978423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.
    Ferreira VM; Ferreira ÍE; Chang HY; Nunes AMPB; Topaz N; Pimentel ER; Moura ARSS; Ribeiro GS; Feitosa CA; Reis MG; Wang X; Campos LC
    Vaccine; 2020 Mar; 38(14):2995-3002. PubMed ID: 32115294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
    Nunes AM; Ribeiro GS; Ferreira ÍE; Moura AR; Felzemburgh RD; de Lemos AP; Reis MG; de Moraes JC; Campos LC
    PLoS One; 2016; 11(11):e0166475. PubMed ID: 27861618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022.
    Rodrigues CMC; MacDonald L; Ure R; Smith A; Cameron JC; Maiden MCJ
    mBio; 2023 Apr; 14(2):e0049923. PubMed ID: 37036356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study.
    Miglietta A; Innocenti F; Pezzotti P; Riccobono E; Moriondo M; Pecile P; Nieddu F; Rossolini GM; Azzari C; ; Balocchini E; Rezza G; Voller F; Stefanelli P
    BMC Infect Dis; 2019 Jan; 19(1):29. PubMed ID: 30621624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.